Predictive Oncology Stock Investor Sentiment
| POAI Stock | USD 1.47 0.08 5.16% |
Under 70% of Predictive Oncology's investor base is looking to short. The analysis of overall sentiment of trading Predictive Oncology stock suggests that many investors are alarmed at this time. Predictive Oncology's investing sentiment shows overall attitude of investors towards Predictive Oncology.
Predictive |
Predictive Oncology Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Predictive Oncology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Predictive Oncology that are available to investors today. That information is available publicly through Predictive media outlets and privately through word of mouth or via Predictive internal channels. However, regardless of the origin, that massive amount of Predictive data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Predictive Oncology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Predictive Oncology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Predictive Oncology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Predictive Oncology alpha.
Predictive Oncology Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Hawryluk Matthew of 18360 shares of Predictive Oncology subject to Rule 16b-3 | 11/04/2024 |
2 | Axonics Modulation Technologies Q3 Earnings and Revenues Top Estimates | 11/07/2024 |
3 | This SolarEdge Technologies Analyst Turns Bearish Here Are Top 5 Downgrades For Friday | 11/15/2024 |
4 | Acquisition by Chung-welch Nancy of 2675 shares of Predictive Oncology subject to Rule 16b-3 | 11/27/2024 |
5 | Acquisition by Engle J Melville of 4512 shares of Predictive Oncology subject to Rule 16b-3 | 12/13/2024 |
6 | Acquisition by Nuzum Charles Lee Sr of 6265 shares of Predictive Oncology subject to Rule 16b-3 | 01/03/2025 |
7 | POAI Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders | 01/06/2025 |
8 | SHAREHOLDER NOTICE Halper Sadeh LLC Investigates RHE, FUBO, POAI on Behalf of Shareholders | 01/07/2025 |
9 | Acquisition by Handley Daniel E of 2800 shares of Predictive Oncology at 0.35 subject to Rule 16b-3 | 01/10/2025 |
10 | Predictive Oncology Announces Planned European Launch of its ChemoFx Treatment Selection Marker and Tumor Profiling Assay | 01/16/2025 |
Complementary Tools for Predictive Stock analysis
When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |